Escitalopram-associated rhabdomyolysis.

Kamilla Kvikstad Mathisen, Randolf Hardersen

Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke 2023 Sep 05

filter terms:

all
compound
phenotype
FDA drugs
show more »
show less «

This case history describes a case of rhabdomyolysis resulting from treatment with escitalopram as monotherapy at the recommended dose. This is a rare and little-known side effect of selective serotonin reuptake inhibitors.

Citation

Kamilla Kvikstad Mathisen, Randolf Hardersen. Escitalopram-associated rhabdomyolysis. Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke. 2023 Sep 05;143(12)